Search Results - "Ruff, C.T."

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48 by Steffel, J, Ruff, C.T, Braunwald, E, Park, J.G, Murphy, S, Antman, E.M, Giugliano, R.P

“…Abstract Background In the phase 3 RCT ENGAGE AF-TIMI 48, both the higher-dose (HDER/edoxaban 60/30mg) and lower-dose edoxaban regimen (LDER/edoxaban 30/15mg)…”
Get full text

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial by Steffel, J, Giugliano, R P, Braunwald, E, Murphy, S A, Atar, D, Heidbuchel, H, Camm, A J, Antman, E M, Ruff, C T

“…In the ENGAGE AF-TIMI 48 trial, the higher-dose edoxaban (HDE) regimen had a similar incidence of ischaemic stroke compared with warfarin, whereas a higher…”
Get full text

P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation by Chao, T.F., Chen, S.A., Fanola, C.L., Mercuri, M.F., Ruff, C.T., Hamershock, R.A., Antman, E.M., Braunwald, E., Giugliano, R.P.

Get full text

5719Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study by De Groot, J.R., Ruff, C.T., Murphy, S.A., Oude Ophuis, A.J.M., Grip, L., Antman, E., Lanz, H., Mercuri, M.F., Braunwald, E., Giugliano, R.P.

Get full text